Springer Nature OA
open access
From Concept to Clinical Trial: Starting Clinical Trials with a New Vaccine
Vaccine development is complex, and there are many things that need to be taken into consideration at every step. The vaccine needs to address an unmet medical need that can be measured in a pivotal phase 3 study. A Target Product Profile (TPP) and a Clinical Development Plan (CDP) are critical for
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure#468153
- Preparing for Adolescent HIV Vaccine Trials in South Africa:#125952
- Motivational Interviewing for Vaccine Uptake in Latinx Adults#1150552
- The landscape for vaccine candidates of COVID-19: is there any relationship between innovation and the business environment of countries?#962232
- Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation#1102290
Record · ID 1428427
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive